17 results
Early Breast Cancer - Management Algorithm
 • Luminal A-like (ER+ and/or PR+, HER2- and low proliferation)
Luminal A-like (ER ... Luminal B-like (ER ... Triple-negative (ER ... Management #Algorithm #treatment ... #oncology
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
Table of Weight-Loss ... the long-term treatment ... - Naltrexone ER ... /Bupropion ER ... #Pharmacology #Table
Treatment of breast cancer: a simplified view
surgical therapy - 5-7 weeks
 - lumpectomy +
 - radiation
Treatment of breast ... 10 years - if ER ... breast #cancer #treatment ... timeline #simplified #oncology
Acute Pulmonary Embolism - Management Algorithms
 - Hemodynamically Stable Patients
 - Hemodynamically Unstable Patients

- Dr. Eric
Acute Pulmonary ... Hemodynamically Stable ... EricsMedicalLectures/ #Pulmonary ... Management #Algorithm #treatment
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... with caution in pulmonary ... with caution in pulmonary ... underlying cause #Stable ... #Tachycardia #Treatment
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... thrombosis; PE = pulmonary ... Management #Hematology #Oncology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Imaging: CXR- pulmonary ... Renal Failure Treatment ... management #hematology #oncology
Differential diagnosis
The table summarizes the most common diseases, that present with consolidation.
Chronic diseases are indicated in
diagnosis The table ... respond to the treatment ... Diagnosis #Radiology #Pulmonary ... #Differential #Table
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
interactions) Cancer-treatment ... #Chemotherapy #Oncology ... #Interactions #Table
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
: 33% • Treatment ... , and CXR with pulmonary ... : No • Treatment ... diagnosis #comparison #table